Skip to main content
. 2003 Apr 22;2003(2):CD000218. doi: 10.1002/14651858.CD000218
Methods Series of random numbers prepared by the pharmacy.
Laboratory assessments were blinded.
Method of allocation concealment not stated.
Participants 186 women with vaginal discharge attending sexually transmitted disease (STD) clinics and family planning clinics in Ontario, Canada.
Partners were treated if seen.
Abstinence from intercourse was advised.
Interventions Metronidazole 1g versus 2 g, both given as single, oral dose.
Outcomes Parasitological and clinical cure. Side effects.
Notes Diagnosis by wetmount confirmed by culture.
Follow up weekly.
Loss to follow up 23/186 (12.4%).
No post‐ randomisation exclusions reported.